Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. Signal., 1 November 2011
Vol. 4, Issue 197, p. ra72
Quelling Inflammation with a Peptide
Members of the interleukin-17 (IL-17) family of cytokines, including IL-17A and IL-25, are implicated in the pathogenesis of various inflammatory conditions, including allergen-induced pulmonary inflammation. Indeed, the concentrations of IL-17A and IL-25 are higher in the lungs of asthmatic patients than in those of unaffected individuals. IL-17A and IL-25 share a common receptor subunit, IL-17RA, to which is recruited the adaptor protein Act1 through interactions between its SEFIR domain and the SEFIR domain of the receptor. Liu et al. identified the CC' loop region within the SEFIR domain of Act1 as critical for receptor-adaptor protein interactions. A cell-permeable peptide based on this region inhibited IL-17– and IL-25–dependent signaling in vitro and reduced disease in a mouse model of pulmonary inflammation, suggesting that such a strategy may provide therapies to treat IL-17–mediated inflammatory diseases in humans.
Citation: C. Liu, S. Swaidani, W. Qian, Z. Kang, P. Sun, Y. Han, C. Wang, M. F. Gulen, W. Yin, C. Zhang, P. L. Fox, M. Aronica, T. A. Hamilton, S. Misra, J. Deng, X. Li, A CC' Loop Decoy Peptide Blocks the Interaction Between Act1 and IL-17RA to Attenuate IL-17– and IL-25–Induced Inflammation. Sci. Signal.4, ra72 (2011).